ENTRY       D01790                      Drug
NAME        Oxaliplatin (JAN/USP/INN);
            Eloxatin (TN)
PRODUCT     OXALIPLATIN (Teva Parenteral Medicines)
  GENERIC   OXALIPLATIN (Accord Healthcare)
            OXALIPLATIN (Actavis Pharma)
            OXALIPLATIN (Apotex Corp.)
            OXALIPLATIN (Baxter Healthcare Corporation)
            OXALIPLATIN (BluePoint Laboratories)
            OXALIPLATIN (Eugia US LLC)
            OXALIPLATIN (FOSUN PHARMA USA)
            OXALIPLATIN (Fosun Pharma USA)
            OXALIPLATIN (Fresenius Kabi USA)
            OXALIPLATIN (Gland Pharma Limited)
            OXALIPLATIN (Gland Pharma Limited)
            OXALIPLATIN (Hospira)
            OXALIPLATIN (Ingenus Pharmaceuticals)
            OXALIPLATIN (Meitheal Pharmaceuticals)
            OXALIPLATIN (Meitheal Pharmaceuticals)
            OXALIPLATIN (Mylan Institutional LLC)
            OXALIPLATIN (Nextgen Pharmaceuticals LLC)
            OXALIPLATIN (NorthStar Rx LLC)
            OXALIPLATIN (Qilu Pharmaceutical)
            OXALIPLATIN (Qilu Pharmaceutical)
            OXALIPLATIN (Sagent Pharmaceuticals)
            OXALIPLATIN (Sandoz)
            OXALIPLATIN (Sandoz)
            OXALIPLATIN (Winthrop U.S.)
            OXALIPLATIN (Winthrop U.S.)
FORMULA     Pt. C6H14N2. C2O4
EXACT_MASS  397.0601
MOL_WEIGHT  397.2918
CLASS       Antineoplastic
             DG01679  Platinum compound
            Transporter substrate
             DG02858  SLC22A1 substrate
             DG02854  SLC22A2 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01XA03
            Product: D01790<JP/US>
EFFICACY    Antineoplastic, Cell growth inhibitor
  DISEASE   Colon cancer [DS:H00020]
            Colorectal cancer [DS:H00020]
COMMENT     Platinum compound
            DNA alkylator
TARGET      DNA
METABOLISM  Transporter: SLC22A2 [HSA:6582], SLC22A1 [HSA:6580]
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
OTHER_MAP   map01524  Platinum drug resistance
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XA Platinum compounds
                 L01XA03 Oxaliplatin
                  D01790  Oxaliplatin (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Alkylating Agents
               Oxaliplatin
                D01790  Oxaliplatin (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D01790  Oxaliplatin (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01679  Platinum compound
               D01790  Oxaliplatin
             Transporter substrate
              DG02858  SLC22A1 substrate
               D01790  Oxaliplatin
              DG02854  SLC22A2 substrate
               D01790  Oxaliplatin
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01790
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01790
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01790
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D01790
DBLINKS     CAS: 61825-94-3
            PubChem: 7848852
            ChEBI: 31941
            LigandBox: D01790
            NIKKAJI: J2.108.891I
ATOM        15
            1   O6a O    27.6304  -16.6769 #-
            2   C6a C    28.8402  -17.3773
            3   C6a C    30.0500  -16.6769
            4   O6a O    31.2599  -17.3773 #-
            5   O6a O    28.8402  -18.7782
            6   O6a O    30.0500  -15.2761
            7   C1x C    18.8079  -16.6698
            8   C1x C    18.8079  -18.0706
            9   C1x C    20.0240  -18.7710
            10  C1y C    21.2329  -18.0706
            11  C1y C    21.2329  -16.6698
            12  C1x C    20.0240  -15.9694
            13  N1a N    22.4327  -15.9781
            14  N1a N    22.4241  -18.7572
            15  Z   Pt   24.9608  -17.2359 #2+
BOND        13
            1     2   3 1
            2     3   4 1
            3     2   5 2
            4     1   2 1
            5     3   6 2
            6     7   8 1
            7     8   9 1
            8     9  10 1
            9    10  11 1
            10   11  12 1
            11   12   7 1
            12   11  13 1 #Up
            13   10  14 1 #Down
///
